Telix Pharmaceuticals Financial Statements
NASDAQ: TLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Telix Pharmaceuticals revenue and earnings
In fiscal 2025, Telix Pharmaceuticals generated $803.8 million in revenue, up 55.6% from fiscal 2024, its 2nd consecutive year of revenue growth. Telix Pharmaceuticals reported a net loss of $7.1 million, compared with net income of $33.7 million a year earlier. Gross margin was 53.1% (down from 65.1%) and operating margin 3.7%.
Diluted earnings per share came in at -$0.0211, down from $0.0976. Over the last 2 fiscal years, TLX's revenue has grown at a 55.4% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Telix Pharmaceuticals income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Revenue | 803.79M | 516.55M | 332.98M |
| Revenue growth (YoY) | +55.61% | +55.13% | — |
| Cost of Revenue | 377.36M | 180.39M | 123.44M |
| Gross Profit | 426.44M | 336.16M | 209.53M |
| Operating Expenses | 396.66M | 280.99M | 198.53M |
| Research & Development | 171.25M | 127.93M | 85.31M |
| Operating Income | 29.78M | 55.18M | 11.01M |
| Interest Expense | 40.87M | 24.44M | 9.09M |
| Other Income (Expense) | 11.73M | 4.88M | -23.83M |
| Pretax Income | -5.27M | 37.91M | 2.59M |
| Income Tax | 1.86M | 4.23M | -1.61M |
| Net Income | -7.13M | 33.69M | 4.21M |
| Net Income growth (YoY) | -121.15% | +700.50% | — |
| EPS (Basic) | -0.0211 | 0.1017 | 0.0132 |
| EPS (Diluted) | -0.0211 | 0.0976 | 0.013 |
| Shares Outstanding (Basic) | 337.88M | 331.23M | 319.18M |
| Shares Outstanding (Diluted) | 337.88M | 345.19M | 323.71M |
| EBITDA | 51.19M | 60.46M | 15.16M |
| Gross Margin | 53.05% | 65.08% | 62.93% |
| Operating Margin | 3.70% | 10.68% | 3.31% |
| Net Margin | -89.00% | 6.52% | 126.00% |
This table shows 3 annual periods of Telix Pharmaceuticals's income statement, from FY 2025 back to FY 2023, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow TLX's reporting calendar. What is a income statement?